Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 Next Page Last Page
 
1
Accelerated Approval (AA) for Oncology Drug Products:

Page 1. 1 Accelerated Approval (AA) for Oncology Drug Products: ... Page 17. 17 Trial Design � Initial AA � Trial design for initial accelerated approval (AA) ...

Center for Biologics Evaluation and Research (CBER)

2
Accelerated Approval Products guidance

... Center for Biologics Evaluation and Research (CBER) under ... still submit as many materials as possible ... report information in labeling material that is ...

Center for Drug Evaluation (CDER)

3
Accelerated approval of oncology products: the food and drug administration experience.
2011-03-21

We reviewed the regulatory history of the accelerated approval process and the US Food and Drug Administration (FDA) experience with accelerated approval of oncology products from its initiation in December 11, 1992, to July 1, 2010. The accelerated ...

PubMed

4
Summary Basis for Approval

... 2 patients who received product for bleeding indications were rated �unable to ... operative period of major surgery, due in part to accelerated consumption. ...

Center for Biologics Evaluation and Research (CBER)

5
Examination of the Relationship Between Oncology Drug Labeling Revision Frequency and FDA Product Categorization
2009-09-01

Objectives. I examined the relationship between the Food and Drug Administration's (FDA's) use of special regulatory designations and the frequency with which labels of oncology drugs are revised to explore how the FDA's designation of products relates to product development and refinement.Methods. One hundred oncology drugs, designated by the FDA as ...

PubMed Central

6
Accelerator Production of Tritium (APT)
1992-01-01

... PARTICLE ACCELERATORS, *TRITIUM, *PRODUCTION ENGINEERING, FEASIBILITY STUDIES, PARTICLE ACCELERATOR TARGETS, HELIUM ...

DTIC Science & Technology

7
Prevnar 13

Product Approval: February 24, 2010 Approval letter and Package Insert, and March 26, 2010 Approval History. ...

Center for Biologics Evaluation and Research (CBER)

8
Beam Trapping in the NRL Modified Betatron Accelerator
1991-05-15

... Descriptors : *BETATRONS. Subject Categories : PARTICLE ACCELERATORS. Distribution Statement : APPROVED FOR PUBLIC RELEASE. ...

DTIC Science & Technology

9
Hiberix

... fifth birthday). Accelerated Approval of Hiberix to Help Sustain Adequate Vaccine Supply Press Release: August 19, 2009; Approval ...

Center for Biologics Evaluation and Research (CBER)

10
Radiation damage issues in accelerator-driven spallation neutron systems
1997-01-01

The development of accelerator-driven systems involving the production of spallation neutrons will require extensive materials data on the response of structural components to the effects of the mixed charged particle and neutron fluxes. Failure to anticipate the potentially strong influence of radiation on material`s performance will most certainly lead ...

DOE Information Bridge

11
Reverse Ion Acceleration by Laser-Matter Interaction
2005-06-01

Approved for public release, distribution unlimited. Reverse Ion Acceleration by Laser-Matter Interaction ... Backward Ion acceleration ? He++ Position ...

DTIC Science & Technology

12
AFLURIA Product Approval Information

... AFLURIA Product Approval Information. ... The following officers or employees of FDA participated in the decision to approve this application and consented to be ...

Center for Biologics Evaluation and Research (CBER)

13
7 CFR 1955.15 - Foreclosure by the Government of loans secured by real estate.
2011-01-01

...Before approval of foreclosure and acceleration of the account, the approval...substances on the property. (2) Acceleration of account. Subject...signed receipt for at least one of these acceleration notices sent by certified mail is...

Code of Federal Regulations, 2011

14
Sterile products: advances and challenges in formulation, manufacturing and regulatory aspects--a regulatory review perspective.
2010-09-16

For several decades, the FDA has undertaken many initiatives to improve the quality and safety of sterile drug products. In recent years, efforts have also been undertaken to accelerate the rate for application approval by adding earlier involvement of microbiology reviewers in drug development. Product and ...

PubMed

15
ANDA approved

... equivalence evaluation of approved applications in the Agency's publication, Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) from ...

Center for Drug Evaluation (CDER)

16
SUBMILLIMETER RADIATION FROM RELATIVISTIC ...
1963-05-03

... Development of a linear accelerator for production of a bunched ... This accelerator was ... Calibration of an analyzing magnet intended to produce, by ...

DTIC Science & Technology

17
REPRODUCTION OF ACCELERATION PROCESSES OF ...
1965-04-15

... OF NUCLEAR REACTORS ON ELECTRON ... equations of reactor acceleration; solution of ... ELECTRIC POWER PRODUCTION, REACTOR KINETICS ...

DTIC Science & Technology

18
AN ACCELERATED METHOD FOR MOISTURE ...
1965-06-01

... Title : AN ACCELERATED METHOD FOR MOISTURE DETERMINATION IN MEAT PRODUCTS AND MEDICAL PREPARATIONS. ...

DTIC Science & Technology

19
A solution to tritium pump contamination for small accelerators.
1969-01-01

Tritium contamination reduction in small ion accelerators for neutron production, discussing pumping

NASA Technical Reports Server (NTRS)

20
22 CFR 204.33 - A.I.D. approval of acceleration of notes.
2011-04-01

...2011-04-01 2011-04-01 false A.I.D. approval of acceleration of notes. 204.33 Section 204.33 Foreign Relations...CONDITIONS Covenants § 204.33 A.I.D. approval of acceleration of notes. Without the prior approval of A.I.D.,...

Code of Federal Regulations, 2011

First Page Previous Page 1 2 Next Page Last Page
 
First Page Previous Page 1 2 Next Page Last Page
 
21
22 CFR 204.33 - A.I.D. approval of acceleration of notes.
2009-04-01

...2009-04-01 2009-04-01 false A.I.D. approval of acceleration of notes. 204.33 Section 204.33 Foreign Relations...CONDITIONS Covenants § 204.33 A.I.D. approval of acceleration of notes. Without the prior approval of...

Code of Federal Regulations, 2010

22
Therapeutic Biological Products Approvals

... Therapeutic Biological Products Approvals. ... For the latest approval information on therapeutic biological products regulated by CDER, please see Drugs@FDA. ...

Center for Drug Evaluation (CDER)

23
STUDY OF PROCESSES FOR THE PRODUCTION OF ...
1962-10-01

Page 1. This report has been reviewed in the Office of Civil Defense and is approved for publication. Approval does not ...

DTIC Science & Technology

24
Accelerating synfuels development
1980-07-01

The Energy Security Act of 1980 establishes a US Synthetic Fuels Corporation (USSFC) to oversee production, which will be financed by assistance to the private sector. The USSFC will function as a private financial institution, but will have a board of directors appointed by the president and approved by congress. The law establishes a 300-employee limit ...

Energy Citations Database

25
Accelerating access to treatments for rare diseases.
2011-06-24

Changes in regulatory policy and legislative incentives to promote the development of drugs for rare diseases - orphan drugs - have led to increases in the number of orphan drug designations, but the rate of such products reaching the market remains frustratingly flat. This article highlights areas in which novel approaches could facilitate regulatory ...

PubMed

26
Lung Cancer Endpoints Final Summary - HTML

... Accelerated approval (AA) allows approval on a less-established surrogate end point, one that is reasonably likely to predict clinical benefit. ...

Center for Drug Evaluation (CDER)

27
FDA Public Workshop on Clinical Trial Endpoints in Prostate Cancer

... The second route to drug approval is accelerated approval (AA), which can be based on a surrogate endpoint that is considered reasonably likely to predict ...

Center for Drug Evaluation (CDER)

28
FDA Approves Thalomid (thalidomide) to Treat Multiple Myeloma

... FDA Approves Thalomid (thalidomide) to Treat Multiple Myeloma. On May 26, 2006, the US Food and Drug Administration granted accelerated ...

Center for Drug Evaluation (CDER)

29
FDA Approval for Lapatinib Ditosylate

As a condition of accelerated approval, subsequent randomized trials are required to verify and describe the clinical benefit of lapatinib in patients with metastatic breast cancer who have received prior treatment with trastuzumab.

Cancer.gov

30
Colorectal Cancer Endpoints Workshop Summary

... The second route to drug approval is accelerated approval (AA), which can be based on a surrogate endpoint that is considered reasonably likely to predict ...

Center for Drug Evaluation (CDER)

31
About the Accelerated Approval Regulations

... Under Subpart H, approval may be based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity ("Surrogate ...

Center for Drug Evaluation (CDER)

32
Investigation of Ion Beam Production and Acceleration Using ...
1984-03-01

... Title : Investigation of Ion Beam Production and Acceleration Using Linear Electron Beams and a Pulse Powered Plasma Focus. ...

DTIC Science & Technology

First Page Previous Page 1 2 Next Page Last Page